Engineering T cell receptor fusion proteins using nonviral CRISPR/Cas9 genome editing for cancer immunotherapy.

Shu R, Hammett M, Evtimov V, Pupovac A, Nguyen NY, Islam R, Zhuang J, Lee S, Kang TH, Lee K, Nisbet I, Hudson P, Lee JY, Boyd R, Trounson A

Open source

DOI: 10.1002/btm2.10571
Published: 2023 Nov
Container: Bioengineering & translational medicine
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/btm2.10571,
  title = {Engineering T cell receptor fusion proteins using nonviral CRISPR/Cas9 genome editing for cancer immunotherapy.},
  author = {Shu R and Hammett M and Evtimov V and Pupovac A and Nguyen NY and Islam R and Zhuang J and Lee S and Kang TH and Lee K and Nisbet I and Hudson P and Lee JY and Boyd R and Trounson A},
  year = {2023},
  journal = {Bioengineering \& translational medicine},
  doi = {10.1002/btm2.10571},
  url = {https://doi.org/10.1002/btm2.10571}
}

RIS

TY  - JOUR
TI  - Engineering T cell receptor fusion proteins using nonviral CRISPR/Cas9 genome editing for cancer immunotherapy.
AU  - Shu R
AU  - Hammett M
AU  - Evtimov V
AU  - Pupovac A
AU  - Nguyen NY
AU  - Islam R
AU  - Zhuang J
AU  - Lee S
AU  - Kang TH
AU  - Lee K
AU  - Nisbet I
AU  - Hudson P
AU  - Lee JY
AU  - Boyd R
AU  - Trounson A
PY  - 2023
JO  - Bioengineering & translational medicine
DO  - 10.1002/btm2.10571
UR  - https://doi.org/10.1002/btm2.10571
ER  -

APA

R, S., M, H., V, E., A, P., NY, N., R, I., J, Z., S, L., TH, K., K, L., I, N., P, H., JY, L., R, B., & A, T. (2023). Engineering T cell receptor fusion proteins using nonviral CRISPR/Cas9 genome editing for cancer immunotherapy.. Bioengineering & translational medicine. https://doi.org/10.1002/btm2.10571

Source records

pubmed · retrieved 2026-09-27T10:08:49.767Z
europe-pmc · retrieved 2026-09-27T10:08:49.758Z
doaj · retrieved 2026-09-27T10:08:49.779Z